AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016
Jul 11, 2016
30583_dirs_2016-07-11_7113a8bf-b6fb-46e3-b1ce-9fa5db14d629.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-06-16
Reporting Person: Davis George Eric (EVP, General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-06-16 | Common Stock | G | 120 | — | Disposed | 72836 | Direct |
| 2016-07-07 | Common Stock | S | 2167 | $90 | Disposed | 70669 | Direct |
Footnotes
F1: On June 16, 2016, the reporting person gifted 120 shares to an educational institution.
F2: Trade made pursuant to a 10b5-1 plan executed on June 14, 2016.
F3: All shares were sold at exactly $90.00.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19